Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 6
2005 5
2006 5
2007 5
2008 7
2009 10
2010 9
2011 5
2012 7
2013 12
2014 15
2015 19
2016 22
2017 16
2018 14
2019 24
2020 27
2021 20
2022 28
2023 25
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

250 results

Results by year

Filters applied: . Clear all
Page 1
Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trials.
Legrand M, Bagshaw SM, Bhatraju PK, Bihorac A, Caniglia E, Khanna AK, Kellum JA, Koyner J, Harhay MO, Zampieri FG, Zarbock A, Chung K, Liu K, Mehta R, Pickkers P, Ryan A, Bernholz J, Dember L, Gallagher M, Rossignol P, Ostermann M. Legrand M, et al. Among authors: gallagher m. Crit Care. 2024 Mar 21;28(1):92. doi: 10.1186/s13054-024-04877-4. Crit Care. 2024. PMID: 38515121 Free PMC article. Review.
Regional Practice Variation and Outcomes in the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial: A Post Hoc Secondary Analysis.
Vaara ST, Serpa Neto A, Bellomo R, Adhikari NKJ, Dreyfuss D, Gallagher M, Gaudry S, Hoste E, Joannidis M, Pettilä V, Wang AY, Kashani K, Wald R, Bagshaw SM, Ostermann M. Vaara ST, et al. Among authors: gallagher m. Crit Care Explor. 2024 Feb 19;6(2):e1053. doi: 10.1097/CCE.0000000000001053. eCollection 2024 Feb. Crit Care Explor. 2024. PMID: 38380940 Free PMC article.
Clinical Adjudication of Hemodialysis Catheter-Related Bloodstream Infections: Findings from the REDUCCTION Trial.
Catiwa J, Gallagher M, Talbot B, Kerr PG, Semple DJ, Roberts MA, Polkinghorne KR, Gray NA, Talaulikar G, Cass A, Kotwal S; REDUCCTION Investigators. Catiwa J, et al. Among authors: gallagher m. Kidney360. 2024 Apr 1;5(4):550-559. doi: 10.34067/KID.0000000000000389. Epub 2024 Feb 8. Kidney360. 2024. PMID: 38329768 Free article. No abstract available.
Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data.
Neuen BL, Jun M, Wick J, Kotwal S, Badve SV, Jardine MJ, Gallagher M, Chalmers J, Nallaiah K, Perkovic V, Peiris D, Rodgers A, Woodward M, Ronksley PE. Neuen BL, et al. Among authors: gallagher m. Lancet Reg Health West Pac. 2023 Dec 18;43:100988. doi: 10.1016/j.lanwpc.2023.100988. eCollection 2024 Feb. Lancet Reg Health West Pac. 2023. PMID: 38192747 Free PMC article.
The Point-of-Care Peritoneal Dialysis System Early Evaluation Study (POC-PDEE): A pilot proof-of-principal study of the Ellen Medical Devices Point-of-Care affordable peritoneal dialysis system.
Talbot B, Davies S, Burman J, Ritchie A, Snelling P, Lynch S, Park Y, Jones B, Garvey V, Jaure A, Jardine M, Perkovic V, Gallagher M, Brandwood A, Kaur N, Knight J. Talbot B, et al. Among authors: gallagher m. Perit Dial Int. 2024 Jan 5:8968608231209850. doi: 10.1177/08968608231209850. Online ahead of print. Perit Dial Int. 2024. PMID: 38179591 Free article.
The Plasma-Lyte 148 versus Saline (PLUS) statistical analysis plan: a multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality.
Billot L, Bellomo R, Gallagher M, Gattas D, Hammond NE, Mackle D, Micallef S, Myburgh J, Navarra L, Saxena M, Taylor C, Young PJ, Finfer S; PLUS Study investigators and the ANZICS Clinical Trials Group. Billot L, et al. Among authors: gallagher m. Crit Care Resusc. 2023 Oct 18;23(1):24-31. doi: 10.51893/2021.1.OA2. eCollection 2021 Mar. Crit Care Resusc. 2023. PMID: 38046395 Free PMC article.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
250 results